NM_016373.4(WWOX):c.101A>G (p.Tyr34Cys) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 11, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000230460.6

Allele description [Variation Report for NM_016373.4(WWOX):c.101A>G (p.Tyr34Cys)]

NM_016373.4(WWOX):c.101A>G (p.Tyr34Cys)

Gene:

WWOX:WW domain containing oxidoreductase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16q23.1

Genomic location:

Preferred name:

NM_016373.4(WWOX):c.101A>G (p.Tyr34Cys)

HGVS:

NC_000016.10:g.78099879A>G
NG_011698.1:g.5226A>G
NM_001291997.2:c.-174A>G
NM_016373.2:c.101A>G
NM_016373.4:c.101A>GMANE SELECT
NM_130791.5:c.101A>G
NP_057457.1:p.Tyr34Cys
NP_570607.1:p.Tyr34Cys
NC_000016.9:g.78133776A>G
NM_016373.3:c.101A>G
NR_120435.2:n.226A>G
NR_120436.3:n.226A>G

Protein change:

Y34C

Links:

dbSNP: rs766309882

NCBI 1000 Genomes Browser:

rs766309882

Molecular consequence:

NM_001291997.2:c.-174A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_016373.4:c.101A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_130791.5:c.101A>G - missense variant - [Sequence Ontology: SO:0001583]
NR_120435.2:n.226A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_120436.3:n.226A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Developmental and epileptic encephalopathy, 1 (DEE1)
Synonyms:: INFANTILE SPASM SYNDROME, X-LINKED 1; X-linked infantile spasms; West's syndrome; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0010632; MedGen: C3463992; OMIM: 308350

Name:: Autosomal recessive spinocerebellar ataxia 12
Synonyms:: SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY
Identifiers:: MONDO: MONDO:0013687; MedGen: C3280452; Orphanet: 284282; OMIM: 614322

Recent activity

Clear Turn Off Turn On

Cylindrobasidium laeve voucher CLZhao 1041 18S ribosomal RNA gene, internal tran...
Cylindrobasidium laeve voucher CLZhao 1041 18S ribosomal RNA gene, internal transcribed spacer 1, 5.8S ribosomal RNA gene, internal transcribed spacer 2, and 28S ribosomal RNA gene, region
gi|1381348224|gb|MG231498.1|

Nucleotide
Cylindrobasidium laeve voucher K(M):181711 small subunit ribosomal RNA gene, par...
Cylindrobasidium laeve voucher K(M):181711 small subunit ribosomal RNA gene, partial sequence; internal transcribed spacer 1, 5.8S ribosomal RNA gene, and internal transcribed spacer 2, complete sequence; and large subunit ribosomal RNA gene, partial sequence
gi|2035162920|gb|MZ159480.1|

Nucleotide
Homo sapiens 211000035842702 genomic scaffold, whole genome shotgun sequence
Homo sapiens 211000035842702 genomic scaffold, whole genome shotgun sequence
gi|71514639|gb|CH471158.1||gnl|WGS: 211000035842702

Nucleotide
Cylindrobasidium laeve voucher AW3559 internal transcribed spacer 1, partial seq...
Cylindrobasidium laeve voucher AW3559 internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequence
gi|1879636312|gb|MT802515.1|

Nucleotide
KATP Channels
KATP Channels
Heteromultimers of Kir6 channels (the pore portion) and sulfonylurea receptor (the regulatory portion) which affect function of the HEART; PANCREATIC BETA CELLS; and KIDNEY CO...<br/>Year introduced: 2008

MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000290217	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jan 11, 2020)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000290217

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jan 11, 2020)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000290217.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a WWOX-related disease. This sequence change replaces tyrosine with cysteine at codon 34 of the WWOX protein (p.Tyr34Cys). There is a large physicochemical difference between tyrosine and cysteine. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine